NCT06118905View on ClinicalTrials.gov

Preserving Geriatric Muscle With an Osteoporosis Medication

PHASE4RecruitingINTERVENTIONAL
Enrollment

155

Participants

Timeline

Start Date

February 8, 2024

Primary Completion Date

February 28, 2029

Study Completion Date

March 31, 2029

Conditions
Osteoporosis
Interventions
DRUG

Denosumab 60 MG/ML

Subjects to receive Denosumab 60mg SQ and Zoledronic acid placebo IV

DRUG

Zoledronic Acid 5Mg/Bag 100Ml Infusion

Subjects to receive Zoledronic Acid 5mg IV and Denosumab placebo

Trial Locations (1)

16059

RECRUITING

St. Barnabas Woodlands, Pittsburgh

All Listed Sponsors
lead

Susan L. Greenspan

OTHER